Top compounds associated with response to CDH3


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CCLE pan-cancer AAC 0.45 2e-17
mRNA Erlotinib gCSI pan-cancer AAC 0.43 7e-11
mRNA KIN001-055 GDSC1000 pan-cancer AAC 0.25 2e-08
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.22 7e-08
mRNA lapatinib gCSI pan-cancer AAC 0.34 1e-07
mRNA EKB-569 GDSC1000 pan-cancer AAC 0.22 1e-07
mRNA Vandetanib CCLE pan-cancer AAC 0.29 1e-07
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.33 2e-07
mRNA lapatinib CCLE pan-cancer AAC 0.27 7e-07
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.21 9e-07
Download CSV